174 related articles for article (PubMed ID: 7591967)
1. Hyperfractionated and hypofractionated radiation therapy for human malignant glioma xenograft in nude mice.
Hasegawa M; Niibe H; Mitsuhashi N; Yamakawa M; Kato S; Furuta M; Kazumoto T; Hayakawa K; Nakazato Y
Jpn J Cancer Res; 1995 Sep; 86(9):879-84. PubMed ID: 7591967
[TBL] [Abstract][Full Text] [Related]
2. The radiation dose-response relationship in a human glioma xenograft and an evaluation of the influence of glutathione depletion by buthionine sulfoximine.
Halperin EC; Brizel DM; Honore G; Sontag MR; Griffith OW; Bigner DD; Friedman HS
Int J Radiat Oncol Biol Phys; 1992; 24(1):103-9. PubMed ID: 1512145
[TBL] [Abstract][Full Text] [Related]
3. Protracted exposure radiosensitization of experimental human malignant glioma.
Williams JA; Williams JR; Yuan X; Dillehay LE
Radiat Oncol Investig; 1998; 6(6):255-63. PubMed ID: 9885941
[TBL] [Abstract][Full Text] [Related]
4. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
Yuan X; Tabassi K; Williams JA
Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162
[TBL] [Abstract][Full Text] [Related]
5. Response of xenografts of human malignant gliomas and squamous cell carcinomas to fractionated irradiation.
Baumann M; DuBois W; Pu A; Freeman J; Suit HD
Int J Radiat Oncol Biol Phys; 1992; 23(4):803-9. PubMed ID: 1319979
[TBL] [Abstract][Full Text] [Related]
6. Ultrafractionation in A7 human malignant glioma in nude mice.
Krause M; Hessel F; Wohlfarth J; Zips D; Hoinkis C; Foest H; Petersen C; Short SC; Joiner MC; Baumann M
Int J Radiat Biol; 2003 Jun; 79(6):377-83. PubMed ID: 12963539
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the response of human FaDu squamous cell carcinoma in nude mice after hypofractionated-accelerated regimens and "curative" fractionation schedules.
Appold S; Baumann M; Petersen C; Horn K; Eichhorn F
Strahlenther Onkol; 1998 Jun; 174(6):315-9. PubMed ID: 9645213
[TBL] [Abstract][Full Text] [Related]
8. White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02).
Corn BW; Yousem DM; Scott CB; Rotman M; Asbell SO; Nelson DF; Martin L; Curran WJ
Cancer; 1994 Nov; 74(10):2828-35. PubMed ID: 7954244
[TBL] [Abstract][Full Text] [Related]
9. Topotecan can compensate for protracted radiation treatment time effects in high grade glioma xenografts.
Pinel S; Chastagner P; Merlin JL; Marchal C; Taghian A; Barberi-Heyob M
J Neurooncol; 2006 Jan; 76(1):31-8. PubMed ID: 16311843
[TBL] [Abstract][Full Text] [Related]
10. Human malignant glioma cell lines are sensitive to low radiation doses.
Beauchesne PD; Bertrand S; Branche R; Linke SP; Revel R; Dore JF; Pedeux RM
Int J Cancer; 2003 May; 105(1):33-40. PubMed ID: 12672027
[TBL] [Abstract][Full Text] [Related]
11. Fractionated Radiotherapy of Intracranial Gliomas.
Ghia AJ
Prog Neurol Surg; 2018; 31():38-47. PubMed ID: 29393175
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
13. Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo.
Krause M; Wohlfarth J; Georgi B; Pimentel N; Dorner D; Zips D; Eicheler W; Hessel F; Short SC; Joiner MC; Baumann M
Int J Radiat Biol; 2005 Oct; 81(10):751-8. PubMed ID: 16449082
[TBL] [Abstract][Full Text] [Related]
14. [The role of age and tumor grade in the choice of fractionation regimen in patients with high-grade gliomas].
Izmaĭlov TR; Pan'shin GA; Datsenko PV
Vopr Onkol; 2012; 58(3):374-9. PubMed ID: 22888654
[TBL] [Abstract][Full Text] [Related]
15. Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma.
Williams JA; Dillehay LE; Tabassi K; Sipos E; Fahlman C; Brem H
J Neurooncol; 1997 May; 32(3):181-92. PubMed ID: 9049879
[TBL] [Abstract][Full Text] [Related]
16. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma.
Yuan X; Dillehay LE; Williams JR; Williams JA
Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft.
Staba MJ; Mauceri HJ; Kufe DW; Hallahan DE; Weichselbaum RR
Gene Ther; 1998 Mar; 5(3):293-300. PubMed ID: 9614548
[TBL] [Abstract][Full Text] [Related]
18. Comparison of accelerated hyperfractionated radiotherapy and conventional radiotherapy for supratentorial malignant glioma.
Shibamoto Y; Nishimura Y; Tsutsui K; Sasai K; Takahashi M; Abe M
Jpn J Clin Oncol; 1997 Feb; 27(1):31-6. PubMed ID: 9070338
[TBL] [Abstract][Full Text] [Related]
19. IUdR polymers for combined continuous low-dose rate and high-dose rate sensitization of experimental human malignant gliomas.
Yuan X; Dillehay LE; Williams JR; Shastri VR; Williams JA
Int J Cancer; 2001 Apr; 96(2):118-25. PubMed ID: 11291095
[TBL] [Abstract][Full Text] [Related]
20. Impact of increased cell loss on the repopulation rate during fractionated irradiation in human FaDu squamous cell carcinoma growing in nude mice.
Hessel F; Petersen C; Zips D; Krause M; Pfitzmann D; Thames HD; Baumann M
Int J Radiat Biol; 2003 Jul; 79(7):479-86. PubMed ID: 14530155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
